Modus Therapeutics Holding AB (publ) (STO:MODTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3700
+0.0110 (3.06%)
Jul 24, 2026, 4:51 PM CET

STO:MODTX Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-18.71--15.84-16.4-18.01-20.69
Other Adjustments
0.01-0.290--0
Change in Receivables
--0.810.48-0.13-0.3-0.35
Changes in Accounts Payable
-0.870.39-0.15-3.414.96
Changes in Other Operating Activities
0.25-----
Operating Cash Flow
-18.460.06-14.68-16.68-21.72-16.08
Purchases of Investments
------0.05
Investing Cash Flow
------0.05
Long-Term Debt Issued
-5-711.5-
Net Long-Term Debt Issued (Repaid)
-5-711.5-
Issuance of Common Stock
-24.58-19.37-33
Net Common Stock Issued (Repurchased)
-24.58-19.37-33
Other Financing Activities
--4.51--1.05--3.57
Financing Cash Flow
20.0725.07-25.3211.529.43
Net Cash Flow
1.6125.13-14.688.64-10.2213.3
Free Cash Flow
-18.460.06-14.68-16.68-21.72-16.08
Free Cash Flow Per Share
-0.220.00-0.41-0.94-1.35-1.30
Levered Free Cash Flow
-13.455.49-15.16-11.05-10.23-15.73
Unlevered Free Cash Flow
0.250.89-15.45-16.55-21.42-15.73